The JAK1/2 Inhibitor Ruxolitinib Downregulates the Immune Checkpoint Protein B7-H3 in Multiple Myeloma

被引：0
|
作者：
Xu, Ning [1 ]
Ng, Nicole [1 ]
Li, Mingjie [1 ]
Yu, Erin [1 ]
Sanchez, Eric [1 ]
Bujarski, Sean [1 ]
Yin, Zhengyi [1 ]
Hekmati, Tara [1 ]
Field, Dylan [1 ]
Wang, Jasper [1 ]
Nassir, Isabella [1 ]
Yu, Janna [1 ]
Huang, Justin [1 ]
Daniely, David [1 ]
Wang, Cathy S. [1 ]
Chen, Haiming [1 ]
Berenson, James R. [1 ]
机构：
[1] Inst Myeloma Bone Canc Res, West Hollywood, CA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1824
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy
    Liu, Chuan
    Zhang, Guangwei
    Xiang, Kanghui
    Kim, Yohan
    Lavoie, Roxane R.
    Lucien, Fabrice
    Wen, Ti
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (07) : 1549 - 1567
  • [32] B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma
    Lu, Zhao
    Zhao, Zhi-Xun
    Cheng, Pu
    Huang, Fei
    Guan, Xu
    Zhang, Ming-Guang
    Chen, Hai-Peng
    Liu, Zheng
    Jiang, Zheng
    Zheng, Zhao-Xu
    Zou, Shuang-Mei
    Wang, Xi-Shan
    MODERN PATHOLOGY, 2020, 33 (11) : 2330 - 2340
  • [33] Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy
    Chuan Liu
    Guangwei Zhang
    Kanghui Xiang
    Yohan Kim
    Roxane R. Lavoie
    Fabrice Lucien
    Ti Wen
    Cancer Immunology, Immunotherapy, 2022, 71 : 1549 - 1567
  • [34] Differential NK-suppressive capacity of the JAK2 inhibitor Pacritinib when compared to the JAK1/2 inhibitor Ruxolitinib
    Wolf, D.
    Rudolph, J.
    Brossart, P.
    Schoenberg, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 26 - 26
  • [35] Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib
    Jaekel, N.
    Behre, G.
    Behning, A.
    Wickenhauser, C.
    Lange, T.
    Niederwieser, D.
    Al-Ali, H. K.
    BONE MARROW TRANSPLANTATION, 2014, 49 (02) : 179 - 184
  • [36] The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases
    Aktimur, Sude H.
    Malkan, Umit Y.
    Eyupoglu, Damla N.
    Haznedaroglu, Ibrahim C.
    Kelkitli, Engin
    Atay, Hilmi M.
    Gunes, Gursel
    Etgul, Sezgin
    Aslan, Tuncay
    Goker, Hakan
    Sayinalp, Nilgun
    Aksu, Salih
    Ozcebe, Osman I.
    Buyukasik, Yahya
    Turgut, Mehmet
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2016, 26 (03): : 153 - 158
  • [37] Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib
    N Jaekel
    G Behre
    A Behning
    C Wickenhauser
    T Lange
    D Niederwieser
    H K Al-Ali
    Bone Marrow Transplantation, 2014, 49 : 179 - 184
  • [38] IMPLICATIONS OF RUXOLITINIB, JAK1/JAK2 INHIBITOR, ON THE GRAFT EFFECT AGAINST LEUKEMIA IN NK CELLS
    Carmen, Mestre-Duran
    Carla, Martin-Cortazar
    Al-Fonso, Navarro-Zapata
    David, Bueno
    Laura, Clares-Villa
    Alicia, Pernas
    Karima, Al-akioui
    Luisa, Sisinni
    Blanca, Garcia-Solis
    Victor, Galan
    Nerea, Matamala
    Adela, Escudero
    Cristina, Ferreras
    Antonio, Perez-Martinez
    HAEMATOLOGICA, 2021, 106 (10) : 29 - 30
  • [39] Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib
    Wilkins, Bridget S.
    Radia, Deepti
    Woodley, Claire
    El Farhi, Sarah
    Keohane, Clodagh
    HAEMATOLOGICA, 2013, 98 (12) : 1872 - 1876
  • [40] The Prognostic Impact of the Mutational Profile in Patients with Myelofibrosis in the Era of the JAK1/JAK2-Inhibitor Ruxolitinib
    Al-Ali, Haifa Kathrin
    Wang, Song-Yau
    Jaekel, Nadja
    Koehler, Anne
    Krahl, Rainer
    Hubert, Karolin
    Lange, Thoralf
    Roskos, Martin
    Stengel, Rayak
    Kovacs, Ines
    Scarlett, Schwabe
    Schubert, Karoline
    Wildenberger, Kathrin
    Schneider, Melanie
    Koehler, Elisabeth
    Niederwieser, Dietger
    BLOOD, 2014, 124 (21)
12345